Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Cotinus coggygria (Fisetin).
Fisetin is a senolytic flavonol that selectively induces apoptosis in senescent cells via inhibition of the PI3K/AKT/mTOR pathway and modulation of the sirtuin-1 (SIRT1) signaling axis.
5281614
286.24 g/mol
2
2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Cotinus coggygria (Fisetin) across standard consumer modalities.
Fisetin exhibits poor aqueous solubility and high first-pass metabolism, requiring micronization or lipid-based carriers within the capsule to ensure consistent therapeutic serum levels.
The high polyphenolic content of fisetin can cause significant astringency and potential cross-linking with pectin matrices, leading to texture hardening and flavor stability issues.
The relatively high therapeutic dose required for senolytic protocols exceeds the typical 20-40mg payload capacity of standard thin-film polymer matrices, necessitating complex loading techniques.
Ready to launch a product featuring Cotinus coggygria (Fisetin)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your Cotinus coggygria (Fisetin) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your Cotinus coggygria (Fisetin) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation